Insider · CIK 0001476971

Thompson Jaye

Reports to the SEC for 3 companies · THE WOODLANDS, TX

sec.gov

Transactions

Companies

Filings

CIK

0001476971

Forms 4 and 5

Insider transactions

34 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-12-24	GLSIGreenwich LifeSciences, Inc. · Stock OptionsA Award	VP Clinical Reg Affairs	AAward	+150K sh	—	—	299,636
2024-11-21	GLSIGreenwich LifeSciences, Inc.P Purchase	VP Clinical Reg Affairs	PPurchase	+1,000 sh	$12.91	+$12.9K	264,148
2024-08-12	GLSIGreenwich LifeSciences, Inc.P Purchase	VP Clinical Reg Affairs	PPurchase	+800 sh	$13.85	+$11.1K	263,148
2024-08-02	GLSIGreenwich LifeSciences, Inc.P Purchase	VP Clinical Reg Affairs	PPurchase	+1,000 sh	$15.15	+$15.2K	262,348
2024-07-18	GLSIGreenwich LifeSciences, Inc.P Purchase	VP Clinical Reg Affairs	PPurchase	+1,000 sh	$16.00	+$16K	261,348
2023-10-27	GLSIGreenwich LifeSciences, Inc.P Purchase	VP Clinical Reg Affairs	PPurchase	+500 sh	$8.57	+$4,285	260,348
2023-09-26	GLSIGreenwich LifeSciences, Inc.P Purchase	VP Clinical Reg Affairs	PPurchase	+600 sh	$8.71	+$5,226	259,848
2023-07-13	GLSIGreenwich LifeSciences, Inc.P Purchase	VP Clinical Reg Affairs	PPurchase	+250 sh	$9.49	+$2,372.5	259,248
2023-04-28	GLSIGreenwich LifeSciences, Inc.P Purchase	VP Clinical Reg Affairs	PPurchase	+250 sh	$11.22	+$2,805	258,998
2023-04-11	GLSIGreenwich LifeSciences, Inc.P Purchase	VP Clinical Reg Affairs	PPurchase	+1,000 sh	$11.87	+$11.9K	258,745
2023-03-15	GLSIGreenwich LifeSciences, Inc.P Purchase	VP Clinical Reg Affairs	PPurchase	+250 sh	$12.71	+$3,177.5	257,745
2023-02-24	GLSIGreenwich LifeSciences, Inc.P Purchase	VP Clinical Reg Affairs	PPurchase	+250 sh	$15.39	+$3,848.75	257,495
2023-02-03	GLSIGreenwich LifeSciences, Inc.P Purchase	VP Clinical Reg Affairs	PPurchase	+250 sh	$20.84	+$5,210	257,245
2023-01-27	GLSIGreenwich LifeSciences, Inc.P Purchase	VP Clinical Reg Affairs	PPurchase	+250 sh	$19.20	+$4,800	256,995
2023-01-13	GLSIGreenwich LifeSciences, Inc.P Purchase	VP Clinical Reg Affairs	PPurchase	+250 sh	$16.50	+$4,125	256,745
2022-12-16	GLSIGreenwich LifeSciences, Inc.P Purchase	VP Clinical Reg Affairs	PPurchase	+250 sh	$12.94	+$3,235	256,495
2022-12-02	GLSIGreenwich LifeSciences, Inc.P Purchase	VP Clinical Reg Affairs	PPurchase	+250 sh	$13.98	+$3,495	256,245
2022-06-22	GLSIGreenwich LifeSciences, Inc. · Stock OptionsA Award	VP Clinical Reg Affairs	AAward	+150K sh	—	—	149,818
2022-04-19	GLSIGreenwich LifeSciences, Inc.P Purchase	VP Clinical Reg Affairs	PPurchase	+500 sh	$16.74	+$8,370	255,995
2022-01-31	GLSIGreenwich LifeSciences, Inc.P Purchase	VP Clinical Reg Affairs	PPurchase	+500 sh	$18.47	+$9,235	255,495
2022-01-21	GLSIGreenwich LifeSciences, Inc.P Purchase	VP Clinical Reg Affairs	PPurchase	+500 sh	$16.33	+$8,165	254,995
2022-01-18	GLSIGreenwich LifeSciences, Inc.P Purchase	VP Clinical Reg Affairs	PPurchase	+500 sh	$18.87	+$9,435	254,495
2022-01-13	GLSIGreenwich LifeSciences, Inc.P Purchase	VP Clinical Reg Affairs	PPurchase	+1,000 sh	$19.99	+$20K	253,995
2016-07-05	REPROS THERAPEUTICS INC.Stock OptionA Award	See Remarks	AAward	+10K sh	—	—	10,000
2013-03-26	REPROS THERAPEUTICS INC.Stock OptionA Award	See Remarks	AAward	+100K sh	—	—	100,000
2012-09-12	Acer Therapeutics Inc.Employee Stock Option (right to buy)A Award	SVP Clinical Dev & Reg Affairs	AAward	+10.5K sh	—	—	10,469
2012-06-13	REPROS THERAPEUTICS INC.Stock OptionA Award	See Remarks	AAward	+5,000 sh	—	—	5,000
2012-01-06	Acer Therapeutics Inc.Employee Stock Option (right to buy)A Award	SVP Clinical Dev & Reg Affairs	AAward	+38.4K sh	—	—	38,388
2011-06-01	REPROS THERAPEUTICS INC.Stock OptionA Award	See Remarks	AAward	+5,000 sh	—	—	5,000
2011-02-28	REPROS THERAPEUTICS INC.Stock OptionA Award	See Remarks	AAward	+40K sh	—	—	40,000
2011-01-04	Acer Therapeutics Inc.Employee Stock Option (Right to Buy)A Award	SVP Clinical Dev & Reg Affairs	AAward	+25K sh	—	—	25,000
2010-05-17	REPROS THERAPEUTICS INC.Stock OptionA Award	See Remarks	AAward	+5,000 sh	—	—	5,000
2009-11-30	Acer Therapeutics Inc.Employee Stock Option (right to buy)A Award	SVP Clinical Dev & Reg Affairs	AAward	+50K sh	—	—	50,000
2009-11-12	REPROS THERAPEUTICS INC.Stock Option (Right to Buy)A Award	See Remarks	AAward	+40K sh	—	—	40,000

Recent filings

Accepted (ET)
Dec 274
Thompson Jaye0001493152-24-052260
SEC(opens sec.gov)
Nov 254
Thompson Jaye0001493152-24-047527
SEC(opens sec.gov)
Sep 164
Thompson Jaye0001493152-24-036275
SEC(opens sec.gov)
Aug 54
Thompson Jaye0001493152-24-030163
SEC(opens sec.gov)
Jul 224
Thompson Jaye0001493152-24-028606
SEC(opens sec.gov)
Oct 314
Thompson Jaye0001493152-23-038777
SEC(opens sec.gov)
Sep 284
Thompson Jaye0001493152-23-034479
SEC(opens sec.gov)
Jul 174
Thompson Jaye0001493152-23-024661
SEC(opens sec.gov)
May 24
Thompson Jaye0001493152-23-015096
SEC(opens sec.gov)
Apr 124
Thompson Jaye0001493152-23-011921
SEC(opens sec.gov)
Mar 164
Thompson Jaye0001493152-23-007822
SEC(opens sec.gov)
Feb 284
Thompson Jaye0001493152-23-006138
SEC(opens sec.gov)
Feb 74
Thompson Jaye0001493152-23-003766
SEC(opens sec.gov)
Jan 304
Thompson Jaye0001493152-23-002849
SEC(opens sec.gov)
Jan 174
Thompson Jaye0001493152-23-001506
SEC(opens sec.gov)
Dec 204
Thompson Jaye0001493152-22-035936
SEC(opens sec.gov)
Dec 64
Thompson Jaye0001493152-22-034537
SEC(opens sec.gov)
Jun 244
Thompson Jaye0001493152-22-017660
SEC(opens sec.gov)
Apr 204
Thompson Jaye0001493152-22-010484
SEC(opens sec.gov)
Feb 14
Thompson Jaye0001493152-22-002817
SEC(opens sec.gov)

Companies

Address

2408 TIMBERLOCH PLACE, B-7

THE WOODLANDS, TX, 77380